转移性恶性实体瘤的临床试验
总计16528个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC完全的
-
Fred Hutchinson Cancer CenterGlobal Life Technologies Corp.暂停
-
National Cancer Institute (NCI)撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Northwestern UniversityGenentech, Inc.完全的未明确的成人实体瘤,特定方案 | 转移癌美国
-
Eli Lilly and CompanyNational Cancer Institute (NCI)完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Accuray Incorporated完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
University of California, San FranciscoSwim Across America招聘中
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)招聘中
-
Tianhong LiNational Cancer Institute (NCI); OncoImmune, Inc.终止
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性腹膜恶性间皮瘤 | 复发性胸膜恶性间皮瘤 | 不可切除的实体瘤 | 晚期胸膜恶性间皮瘤 | 晚期腹膜恶性间皮瘤美国
-
Advanced Integrative Medical Science Institute招聘中
-
Vion Pharmaceuticals完全的
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
The First Affiliated Hospital of Guangzhou Medical...Sinotau Pharmaceutical Group完全的
-
Sanofi终止恶性实体瘤法国, 西班牙, 澳大利亚, 比利时, 意大利, 英国, 台湾, 爱沙尼亚, 荷兰, 大韩民国, 美国, 加拿大, 德国
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Shenzhen Second People's Hospital未知
-
Symphogen A/S主动,不招人